YOUR NEXT CHAPTER
Feel informed, strong and at home in your changing body
Keep learning about the changes that shape energy, strength, confidence and wellbeing through midlife.
Explore Resources
Galderma reported interim injectable-treatment findings in menopausal women. We assess the skin outcomes, evidence gaps and implications for care.
Compare menopause facial-hair options, from daily removal to laser, electrolysis and prescriptions, with realistic expectations about growth and upkeep.
A dermatologist’s perspective on midlife dryness, sensitivity and firmness explains why menopause, aging and sun exposure belong in the same assessment.
Facial estrogen creams have a plausible rationale, but visible benefits and safety remain uncertain. A closer look at the evidence and company claims.
Hair extensions may add fullness to thinning hair. A new report examines individual suitability, traction risk and why medical assessment still matters.
WHO includes skin and mucosal changes in its early-menopause feature, calling for better evidence and broader, person-centered care.
A dermatologist explains why chin hairs may appear in perimenopause without high testosterone, and which changes deserve a medical conversation.
How a women’s health symposium sharpened the questions behind skin and hair claims, from the formulation tested to the women and outcomes studied.
Galderma’s menopause skin survey and injectable trial, with their evidence limits and the AAD’s guidance on routine care and assessment.
A CRN Convergence report raises questions about midlife hair-supplement claims. Here is how to weigh the evidence alongside dermatology advice.
WHO’s early-menopause feature calls for stronger long-term evidence. Here is how to read its relevance to skin changes and treatment claims.
A Dermatology Times interview supports reviewing skin-care goals after acne control, with AAD context on menopause, dryness and sun protection.
Dermatologists discuss possible causes of thinning brows in midlife, gentle care and clinician-supervised off-label treatment considerations.
A clear look at clascoterone, VDPHL01 and PP405 trial updates, their findings and the evidence still needed for women with midlife hair thinning.
Compare mature-skin serum claims through formulation, evidence and current skin needs, with AAD guidance on protection, dryness and assessment.
Dermatologists explain possible links between perimenopause and skin flares, how sensitivity differs from eczema, and when persistent irritation needs care.
Small hair-supplement trials report benefits. Read how the findings fit AAD guidance on evidence quality, clinical assessment and documented deficiencies.
Analyze commercial menopause skincare claims and clinical evidence, helping women separate aggressive marketing from facts about midlife physical changes.
Keep learning about the changes that shape energy, strength, confidence and wellbeing through midlife.
Explore Resources
